EP4691243A1 - Antibacterial agent and method for using composition containing silicon nitride as antibacterial agent - Google Patents

Antibacterial agent and method for using composition containing silicon nitride as antibacterial agent

Info

Publication number
EP4691243A1
EP4691243A1 EP24780368.7A EP24780368A EP4691243A1 EP 4691243 A1 EP4691243 A1 EP 4691243A1 EP 24780368 A EP24780368 A EP 24780368A EP 4691243 A1 EP4691243 A1 EP 4691243A1
Authority
EP
European Patent Office
Prior art keywords
antibacterial agent
silicon nitride
content
mass ppm
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24780368.7A
Other languages
German (de)
English (en)
French (fr)
Inventor
Kenji Miyata
Hideyuki Emoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denka Co Ltd
Original Assignee
Denka Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denka Co Ltd filed Critical Denka Co Ltd
Publication of EP4691243A1 publication Critical patent/EP4691243A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00Disinfectants; Antimicrobial compounds or mixtures thereof
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B21/00Nitrogen; Compounds thereof
    • C01B21/06Binary compounds of nitrogen with metals, with silicon, or with boron, or with carbon, i.e. nitrides; Compounds of nitrogen with more than one metal, silicon or boron
    • C01B21/068Binary compounds of nitrogen with metals, with silicon, or with boron, or with carbon, i.e. nitrides; Compounds of nitrogen with more than one metal, silicon or boron with silicon
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B21/00Nitrogen; Compounds thereof
    • C01B21/06Binary compounds of nitrogen with metals, with silicon, or with boron, or with carbon, i.e. nitrides; Compounds of nitrogen with more than one metal, silicon or boron
    • C01B21/068Binary compounds of nitrogen with metals, with silicon, or with boron, or with carbon, i.e. nitrides; Compounds of nitrogen with more than one metal, silicon or boron with silicon
    • C01B21/0682Preparation by direct nitridation of silicon
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B21/00Nitrogen; Compounds thereof
    • C01B21/06Binary compounds of nitrogen with metals, with silicon, or with boron, or with carbon, i.e. nitrides; Compounds of nitrogen with more than one metal, silicon or boron
    • C01B21/068Binary compounds of nitrogen with metals, with silicon, or with boron, or with carbon, i.e. nitrides; Compounds of nitrogen with more than one metal, silicon or boron with silicon
    • C01B21/0687After-treatment, e.g. grinding, purification

Definitions

  • the present disclosure relates to an antibacterial agent and a method for using a composition containing silicon nitride as an antibacterial agent.
  • Silicon nitride is a material that has excellent strength, hardness, toughness, heat resistance, corrosion resistance, and thermal shock resistance, etc., and therefore, is used in components in various kinds of structures. As well as the foregoing characteristics, silicon nitride is also known for having antibacterial properties and biocompatibility (Patent Documents 1 and 2). Patent Document 1 proposes changing surface chemical characteristics in order to improve the antibacterial properties of a biomedical implant block which includes a silicon nitride ceramic material. Patent Document 2 proposes: filling silicon nitride in a biomedical implant of polyether ether ketone (PEEK), or the like; and providing a silicon nitride coating.
  • PEEK polyether ether ketone
  • the present disclosure provides an antibacterial agent having excellent antibacterial properties.
  • the present disclosure provides a method for using a composition containing silicon nitride as an antibacterial agent having excellent antibacterial properties.
  • One aspect of the present disclosure provides the antibacterial agent described below.
  • the antibacterial properties of silicon nitride change depending on the fluorine content.
  • the composition described above contains silicon nitride as a main component and has a fluorine content of 900 mass ppm or less, and therefore, has excellent antibacterial properties. Such a composition has excellent antibacterial properties, and therefore, is preferred as an antibacterial agent.
  • an antibacterial agent having excellent antibacterial properties it is possible to provide a method for using a composition containing silicon nitride as an antibacterial agent having excellent antibacterial properties.
  • An antibacterial agent in one embodiment contains silicon nitride as a main component and has a fluorine content of 900 mass ppm or less.
  • the antibacterial agent may, for example, be granular, may be a powder configured by aggregating a plurality of particles, and may be a solid body such as a film, etc.
  • a "silicon nitride powder” refers to a powder having a silicon nitride content of 90 mass% or more.
  • Such a silicon nitride powder may be an antibacterial agent.
  • main component refers to a component with the largest content.
  • a component other than the "main component” is referred to as an "accessory component".
  • the antibacterial agent may consist solely of a main component or may include a main component and an accessory component.
  • the content of the silicon nitride in the antibacterial agent may be 90 mass% or more, 95 mass% or more, 98 mass% or more, 99 mass% or more, 99.5 mass% or more, or 99.7 mass% or more.
  • the antibacterial performance of the antibacterial agent tend to improve with a higher content of silicon nitride therein.
  • an accessory component included in the antibacterial agent include fluorine, chlorine, oxygen, iron, aluminum, and calcium, etc. The foregoing may also form a compound.
  • the fluorine content in the antibacterial agent may be 700 mass ppm or less, 500 mass ppm or less, 300 mass ppm or less, 250 mass ppm or less, 100 mass ppm or less, or 60 mass ppm or less.
  • Antibacterial performance tend to improve with a low fluorine content.
  • One factor therefor is thought to be that with a low fluorine content, when hydrolysis occurs due to coming into contact with water, the ratio of ammonia (NH 3 ) with respect to ammonium ions (NH 4 + ) increases.
  • the fluorine content in the antibacterial agent varies depending on raw material constitution when producing the antibacterial agent, and on whether or not a surface treatment is performed. For example, it is possible to lower the fluorine content by sufficiently washing the antibacterial agent using a washing liquid such as water, etc.
  • the fluorine content in the antibacterial agent may be 10 mass ppm or more, 20 mass ppm or more, or 30 mass ppm or more. Setting such a content makes it possible to lower antibacterial agent production costs.
  • the fluorine content in the antibacterial agent may be 10-900 mass ppm.
  • the chlorine content in the antibacterial agent may be 30 mass ppm or more, 50 mass ppm or more, 100 mass ppm or more, 300 mass ppm or more, 400 mass ppm or more, or 500 mass ppm or more. With a high chlorine content, antibacterial performance tends to improve, particularly with respect to Gram-negative bacteria.
  • the chlorine content in the antibacterial agent varies depending on raw material constitution when producing the antibacterial agent and on whether or not a particle surface treatment is performed. For example, when the raw materials used to synthesize silicon nitride have a high chlorine content, there is a tendency for the content of chlorine in the antibacterial agent to be high.
  • the chlorine content in the antibacterial agent may be 1000 mass ppm or less, 800 mass ppm or less, or 700 mass ppm or less. Setting such a content makes it possible to suppress chlorine-derived corrosion. As an example, the chlorine content in the antibacterial agent may be 30-1000 mass ppm.
  • the oxygen content in the antibacterial agent may be 2.0 mass% or less, 1.5 mass% or less, or 1.0 mass% or less.
  • Oxygen may, for example, be included as silicon dioxide (SiO 2 ). With a low oxygen content in the antibacterial agent, antibacterial performance tends to improve.
  • the oxygen content in the antibacterial agent varies depending on raw material constitution when producing the antibacterial agent and on firing atmosphere. For example, if the oxygen concentration in a firing atmosphere is made low when synthesizing the silicon nitride by a direct nitridation method, there is a tendency for the oxygen content in the antibacterial agent to be low.
  • the oxygen content in the antibacterial agent may be 0.2 mass% or more, 0.4 mass% or more, or 0.5 mass% or more. Setting such a content enables the use of low purity raw materials and gas and makes it possible to lower antibacterial agent production costs. As an example, the oxygen content in the antibacterial agent may be 0.2-2.0 mass%.
  • the total content of aluminum, iron, and calcium in the antibacterial agent may be 2000 mass ppm or less or 1800 mass ppm or less. By reducing the total content of aluminum, iron, and calcium, the silicon nitride content increases, and thus, antibacterial performance tends to improve.
  • the total content of aluminum, iron, and calcium in the antibacterial agent may be 10 mass ppm or more, 50 mass ppm or more, 500 mass ppm or more, or 1000 mass ppm or more. Setting such a content enables the use of low purity raw materials and makes it possible to lower antibacterial agent production costs.
  • the total content of aluminum, iron, and calcium in the antibacterial agent may be 10-2000 mass ppm.
  • the respective contents of fluorine, chlorine, oxygen, aluminum, iron, and calcium in the antibacterial agent can be measured by a method described in the examples.
  • the antibacterial agent may contain an accessory component other than those described above.
  • the silicon nitride may have an ⁇ conversion ratio (phase ratio of ⁇ -Si 3 N 4 with respect to Si 3 N 4 ) of 80% or more, 85% or more, 88% or more, or 90% or more. If the ⁇ conversion ratio is made high, there is a tendency for antibacterial performance to improve with respect to Gram-negative bacteria.
  • the silicon nitride ⁇ conversion ratio may be 99% or less, 97% or less, or 96% or less. Setting such a value makes it possible to lower antibacterial agent production costs.
  • the silicon nitride ⁇ conversion ratio may be 80-99%.
  • the silicon nitride ⁇ conversion ratio can be adjusted by, for example, changing firing conditions (for example, firing temperature and firing time) when performing firing to synthesize silicon nitride.
  • the BET specific surface area of the antibacterial agent may be 0.5 m 2 /g or more, 1.0 m 2 /g or more, 2.0 m 2 /g or more, 5.0 m 2 /g or more, or 7.0 m 2 /g or more.
  • the BET specific surface area can be adjusted by changing firing conditions (for example, firing temperature and firing time) when synthesizing silicon nitride, and the size of the raw material powder.
  • the BET specific surface area of the antibacterial agent may be 20 m 2 /g or less, 15 m 2 /g or less, or 10 m 2 /g or less. Setting such a value makes it possible to improve the handleability of the antibacterial agent.
  • the BET specific surface area is 0.5-20 m 2 /g.
  • the BET specific surface area can be measured by a method described in the examples.
  • the average particle diameter (D50, median diameter) may be 20 ⁇ m or less, 10 ⁇ m or less, 3 ⁇ m or less, or 1 ⁇ m or less.
  • the average particle diameter may be 0.2 ⁇ m or more, 0.3 ⁇ m or more, or 0.5 ⁇ m or more.
  • the average particle diameter is 0.2-20 ⁇ m.
  • a particle diameter distribution is measured in compliance with the method described in "particle diameter analysis laser - diffraction/scattering method" of JIS Z 8825: 2013.
  • a particle diameter distribution cumulative distribution
  • the particle diameter at which an integrated value from a small particle diameter reaches 50% of the total is the average particle diameter (D50) described above.
  • a particle diameter (D10) at which an integrated value from a small particle diameter reaches 10% of the total may be 0.1-5 ⁇ m or 0.1-0.5 ⁇ m.
  • a particle diameter (D90) at which an integrated value from a small diameter reaches 90% of the total may be 0.8-5.0 ⁇ m or 1.0-3.0 ⁇ m.
  • D10, D50, and D90 can be adjusted by, for example, changing firing conditions (for example, firing temperature and firing time) when performing firing to synthesize silicon nitride, or by changing grinding conditions after firing.
  • an elution amount of fluorine eluted from the antibacterial agent to the liquid phase may be 250 mass ppm or less, 200 mass ppm or less, 100 mass ppm or less, 70 mass ppm or less, 30 mass ppm or less, or 10 mass ppm or less.
  • a small fluorine elution amount antibacterial performance tends to improve.
  • One factor therefor is thought to be that with a small fluorine elution amount, the ratio of ammonia with respect to ammonium ions in the liquid phase tends to increase.
  • the fluorine elution amount varies depending on the fluorine content near the surface of the antibacterial agent. For example, it is possible to lower the fluorine elution amount by sufficiently washing the antibacterial agent using a washing liquid such as water, etc.
  • the fluorine elution amount may be 1 mass ppm or more, 3 mass ppm or more, or 5 mass ppm or more. Setting such a value makes it possible to lower antibacterial agent production costs.
  • the fluorine elution amount is 1-250 mass ppm.
  • an elution amount of fluorine eluted from the antibacterial agent to the liquid phase (water phase) may also be in the ranges described above.
  • an elution amount of chlorine eluted from the antibacterial agent to the liquid phase may be 10 mass ppm or more, 20 mass ppm or more, or 40 mass ppm or more.
  • an elution amount of chlorine eluted from the antibacterial agent to the liquid phase may be 10 mass ppm or more, 20 mass ppm or more, or 40 mass ppm or more.
  • the chlorine elution amount varies depending on the chlorine content near the surface of the antibacterial agent.
  • the chlorine content near the surface of the antibacterial agent varies depending on raw material constitution when producing the antibacterial agent. For example, with a high content of chlorine in the raw materials, the chlorine elution amount tends to be large.
  • the chlorine elution amount may be 200 mass ppm or less, 100 mass ppm or less, or 80 mass ppm or less. Setting such an amount makes it possible to suppress chlorine-derived corrosion.
  • the chlorine elution amount is 10-200 mass ppm.
  • the fluorine elution amount may be 1-250 mass ppm.
  • an elution amount of chlorine eluted from the antibacterial agent to the liquid phase may also be in the ranges described above.
  • An elution amount herein is synonymous with a content in a liquid phase. Accordingly, an elution amount to a liquid phase is determined by measuring a content in the liquid phase. The elution amount is obtained under conditions of atmospheric pressure and a temperature of 20°C. Measurement can be performed by a method described in the examples.
  • the unit "w/v%" is synonymous with "g/100 mL”.
  • the pH of the liquid phase (water phase) is 7.0 or more, 7.5 or more, 8.0 or more, or 8.5 or more.
  • the pH of the liquid phase may be 10 or less or 9.5 or less.
  • the pH of the liquid phase can be adjusted by changing the constitution of the surface of the antibacterial agent.
  • the pH of the liquid phase may be 7.0-10.0.
  • the pH of the liquid phase water phase
  • the content of ammonium ions included in the liquid phase may be 6.0 ⁇ g/mL or less, 5.0 ⁇ g/mL or less, or 4.0 ⁇ g/mL or less. If the content of ammonium ions in the liquid phase is reduced, the content of ammonia in the liquid phase can be increased. Doing so makes it possible to improve the antibacterial performance of the antibacterial agent.
  • the content of ammonium ions may be 0.5 ⁇ g/mL or more or 1.0 ⁇ g/mL or more.
  • the range of the content of ammonium ions included in the liquid phase may be 0.5-6.0 ⁇ g/mL.
  • the antibacterial agent is dispersed in water so as to have a concentration of 3.6 w/v%, after ten minutes have elapsed, the content of ammonium ions included in the liquid phase may also be in the ranges described above.
  • the content of ammonia included in the liquid phase may be 0.2 ⁇ g/mL or more, 0.3 ⁇ g/mL or more, or 0.4 ⁇ g/mL or more. Such an antibacterial agent tends to have even more excellent antibacterial properties.
  • the ammonia content may be 2.0 ⁇ g/mL or less or 1.0 ⁇ g/mL or less.
  • the range of the content of ammonia included in the liquid phase is 0.2-1.0 ⁇ g/mL.
  • the content of ammonia included in the liquid phase may also be the in the ranges described above.
  • a ratio (NH 3 /NH 4 + ) of the content of ammonia with respect to the content of ammonium ions in the liquid phase may be 0.10 or more, 0.12 or more, or 0.14 or more. Such an antibacterial agent tends to have even more excellent antibacterial properties.
  • the above ratio (NH 3 /NH 4 + ) may be 1.0 or less or 0.5 or less.
  • the contents of ammonia and ammonium ions in the liquid phase and the pH are measured by methods described in the examples under conditions of atmospheric pressure and a temperature of 20°C.
  • the zeta potential of the liquid phase may be -10 mV or less, -20 mV or less, -30 mV or less, or -40 mV or less.
  • Such an antibacterial agent has both excellent antibacterial properties and excellent biocompatibility.
  • the zeta potential of the liquid phase may also be in the ranges described above.
  • a powdery antibacterial agent can, for example, be prepared by subjecting a silicon nitride powder obtained by a publicly-known method such as direct nitridation, imide thermal decomposition, or combustion synthesis, etc., to a surface treatment and washing with water, as required.
  • the production method is not particularly limited.
  • the prepared silicon nitride powder can be dispersed in a resin or adhered to a fiber to produce antibacterial products of various forms.
  • the antibacterial agent of the present embodiment has excellent antibacterial properties with respect to both Gram-positive bacteria and Gram-negative bacteria.
  • the antibacterial agent can also be referred to as an antibacterial composition.
  • the form of the antibacterial agent is not particularly limited and may, for example, be a powder, bulk, thin film, or coating. A powdery antibacterial agent may be dispersed in a matrix such as a film or filter, etc.
  • the antibacterial agent has excellent antibacterial properties and also has biocompatibility. Due thereto, the antibacterial agent can, for example, be coated on a biomedical implant.
  • a method is a method for using a composition that contains silicon nitride as a main component and has a fluorine content of 900 mass ppm or less as an antibacterial agent.
  • the composition contains silicon nitride as a main component.
  • the contents of the main component and accessory components are as described in the embodiment of an antibacterial agent.
  • the details described in the embodiment of an antibacterial agent also apply to the use method of the present embodiment. That is, the composition may contain the same components as the antibacterial agent described above and may have the same form and characteristics as the antibacterial agent described above.
  • the form of the composition is not particularly limited and may, for example, be a powder, bulk, thin film, or coating.
  • a powdery composition may be dispersed in a matrix such as a film or filter, etc.
  • the composition used in the method of the present embodiment has excellent antibacterial properties, and therefore, can be preferably used as an antibacterial agent.
  • a raw material was prepared by blending a silicon powder and calcium fluoride. At that time, the calcium fluoride was blended at a ratio of 1.5 mass% with respect to the silicon powder.
  • the raw material was used to fabricate a compact (bulk density: 1.4 g/cm 3 ), and the compact was fired for 60 hours at 1400°C using an electric furnace to fabricate a silicon nitride ingot.
  • the obtained ingot was coarse ground and then wet ground in a ball mill.
  • a post-treatment was performed in which the silicon nitride powder obtained by the wet grinding was immersed in hydrofluoric acid (concentration: 10 mass%) for two hours at a temperature of 60°C. Thereafter, the silicon nitride powder was extracted from the hydrofluoric acid, washed with water, and dried in a nitrogen atmosphere. Thus, the silicon nitride powder (antibacterial agent) of Example 1 was obtained.
  • the respective contents of fluorine and chlorine included in the silicon nitride powder were measured using the procedure described below.
  • An automatic sample combustion device (device name: AQF-2100H, manufactured by Mitsubishi Chemical Corporation) was used to heat the silicon nitride powder and gas that was generated was dissolved in water.
  • An ion chromatograph (device name: ICS-2100, manufactured by Thermo Fisher Scientific Inc.) was used to measure fluorine and chlorine dissolved in the water in compliance with JIS 1603: 2007.
  • the quantities of fluorine and chlorine included in the silicon nitride powder were determined on the basis of values obtained by the foregoing measurement. Measurement results were as shown in Table 1.
  • An X-ray fluorescence spectrometer (device name: ZSX-Primus II, manufactured by Rigaku Corporation) was used to measure the respective contents of Fe (iron), Al (aluminum), and Ca (calcium) in the silicon nitride powder. Each of the contents is shown in Table 1.
  • the ⁇ conversion ratio of the silicon nitride was measured using the procedure described below.
  • An X-ray diffraction device (device name: Ultima IV, manufactured by Rigaku Corporation) was used to perform X-ray diffraction on the silicon nitride using a CuKa beam.
  • An ⁇ phase was represented by a diffraction beam intensity l a102 of a (102) surface and a diffraction beam intensity l a210 of a surface (210), and a ⁇ phase was represented by a diffracted beam intensity l b101 of a (101) surface and a diffraction beam intensity l b210 of the (210) surface.
  • the diffraction beam intensities were used to calculate the ⁇ conversion ratio by the formula below. The results are shown in Table 1.
  • ⁇ conversion ratio % I a 102 + I a 210 / I a 102 + I a 210 + I b 101 + I b 210 ⁇ 100
  • the BET specific surface area of the silicon nitride powder was measured by a single point BET method using nitrogen gas in compliance with JIS Z 8830: 2013 "Method for measuring specific surface area of powder (solid) by gas adsorption”. The results are shown in the "SSA" row in Table 1.
  • the particle diameter distribution of the silicon nitride powder was measured by a laser diffraction/scattering method. Measurement was performed in compliance with the method described in JIS Z 8825: 2013 "Particle diameter analysis laser diffraction/scattering method". In a particle diameter distribution (cumulative distribution) with a logarithmic scale particle diameter [ ⁇ m] shown on the horizontal axis and frequency [vol.%] shown on the vertical axis, the particle diameters at which an integrated value from a small particle diameter reaches 10%, 50%, and 90% of the total were respectively determined as D10, D50, and D90. The results are shown in Table 1.
  • the respective quantities of fluorine, chlorine, ammonia (NH 3 ), and ammonium ions (NH 4 + ) in the filtrate were determined by an ion chromatograph (device name: ICS-2100, manufactured by Thermo Fisher Scientific Inc.).
  • a pH meter (device name: FP20-Std-Kit, manufactured by Mettler Toledo) was used to measure the pH of the filtrate.
  • a zeta potential analyzer (device name: ELSZneo, manufactured by Otsuka Electronics Co., Ltd.) was used to measure the zeta potential of the filtrate.
  • a bacterial suspension (1 ⁇ 10 5 to 1 ⁇ 10 6 CFU/mL) was prepared by pre-culturing bacteria (Staphylococcus aureus) in a BHI liquid culture medium.
  • a 15 w/v% dispersion liquid was obtained by putting 0.15 g of the silicon nitride powder and 1 mL of distilled water into a microtube. After sterilizing the microtube with ultraviolet light, 1 mL of the bacterial suspension described above was added to the microtube. Then, after mixing for five minutes at room temperature (approximately 20°C) in a tube rotator, the supernatant was collected and the amount of viable bacteria was measured by using a WST-8 assay (absorbance of 450 nm).
  • Viability was measured in the same manner when Staphylococcus epidermidis or when Escherichia coli was used as the bacteria. The results are shown in Table 1. Viability results when the silicon nitride powder was not used are shown in the "ref" column of Table 1.
  • Air inside a vertical reaction tank was replaced with nitrogen gas and then liquid ammonia and toluene were introduced.
  • the liquid ammonia and the toluene separated into, respectively, an upper layer and a lower layer.
  • a toluene solution including silicon tetrachloride at a concentration of 20-35 mass% with the remainder being toluene was slowly supplied, through a conduit attached to the vertical reaction tank, to the lower layer as the lower layer was stirred.
  • a white reaction product (silicon diimide) precipitated near the interface of the upper and lower layers.
  • the reaction liquid inside the vertical reaction tank was transferred to a filtration tank and the product was filtered.
  • the product was washed with liquid ammonia to purify the silicon diimide.
  • the purified silicon diimide was decomposed by being heated at approximately 1500°C in a nitrogen atmosphere to obtain a silicon nitride powder.
  • the silicon nitride powder was used as the silicon nitride powder (antibacterial agent) of Example 2.
  • An evaluation of the silicon nitride powder was carried out using the same procedure as Example 1. Each of the evaluation results was as shown in Table 1.
  • a commercially sold silicon nitride powder (product name: HP for PV, manufactured by Höganäs) was used as the silicon nitride powder (antibacterial agent) of Comparative Example 1.
  • An evaluation of the silicon nitride powder was carried out using the same procedure as Example 1. Each of the evaluation results was as shown in Table 1.
  • the powders were mixed for 12 hours in methanol using balls made of silicon nitride and a container made of polyethylene.
  • the obtained slurry underwent filtration separation and was then vacuum-dried at 100°C to obtain a pre-mixed powder.
  • Approximately 10 g of the pre-mixed powder was loaded into a porous refractory container and then underwent combustion synthesis in a 10 MPa nitrogen atmosphere using a high-pressure container of an HIP device.
  • the loaded powder was ignited by heat generated by the self-combustion of Ti upon nitriding when 20 mm-diameter Ti pellets placed on top of the powder were strongly heated for several seconds using a ribbon-shaped carbon heater.
  • the product created by the combustion was significantly aggregated due to the high temperature during the combustion synthesis. Further, the particles included in the product had themselves also undergone grain growth.
  • Approximately 100 g of the product was wet ground for 72 hours in methanol using balls made of silicon nitride and a container made of polyethylene to obtain a slurry. After performing filtration separation on the slurry, the obtained solid content was vacuum dried at 100°C to obtain a silicon nitride powder.
  • the silicon nitride powder was used as the silicon nitride powder (antibacterial agent) of Example 3.
  • An evaluation of the silicon nitride powder was carried out using the same procedure as Example 1. Each of the evaluation results was as shown in Table 1.
  • the silicon nitride powder of Example 3 was ground using a planetary ball mill (device name: PM100, manufactured by Retsch). The grinding time was 60 minutes. The ground silicon nitride powder was used as the silicon nitride powder (antibacterial agent) of Example 4. Each of the evaluation results was as shown in Table 1.
  • a commercially sold silicon nitride powder (product name: M11, manufactured by Höganäs) was used as the silicon nitride powder (antibacterial agent) of Comparative Example 2.
  • An evaluation of the silicon nitride powder was carried out using the same procedure as Example 1. Each of the evaluation results was as shown in Table 2.
  • Example 5 A powder obtained by performing two repetitions of the washing by distilled water carried out in Example 5 was used as the silicon nitride powder (antibacterial agent) of Example 6. An evaluation of the silicon nitride powder was carried out using the same procedure as Example 1. Each of the evaluation results was as shown in Table 2.
  • Example 7 A powder obtained by performing three repetitions of the washing by distilled water carried out in Example 5 was used as the silicon nitride powder (antibacterial agent) of Example 7. An evaluation of the silicon nitride powder was carried out using the same procedure as Example 1. Each of the evaluation results was as shown in Table 2.
  • Example 8 A powder obtained by performing four repetitions of the washing by distilled water carried out in Example 5 was used as the silicon nitride powder (antibacterial agent) of Example 8. An evaluation of the silicon nitride powder was carried out using the same procedure as Example 1. Each of the evaluation results was as shown in Table 2.
  • an antibacterial agent having excellent antibacterial properties it is possible to provide a method for using a composition containing silicon nitride as an antibacterial agent having excellent antibacterial properties.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EP24780368.7A 2023-03-27 2024-03-26 Antibacterial agent and method for using composition containing silicon nitride as antibacterial agent Pending EP4691243A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023050284 2023-03-27
PCT/JP2024/012068 WO2024204260A1 (ja) 2023-03-27 2024-03-26 抗菌剤、及び窒化ケイ素を含有する組成物を抗菌剤として使用する方法

Publications (1)

Publication Number Publication Date
EP4691243A1 true EP4691243A1 (en) 2026-02-11

Family

ID=92905460

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24780368.7A Pending EP4691243A1 (en) 2023-03-27 2024-03-26 Antibacterial agent and method for using composition containing silicon nitride as antibacterial agent

Country Status (4)

Country Link
EP (1) EP4691243A1 (https=)
JP (1) JPWO2024204260A1 (https=)
CN (1) CN120882313A (https=)
WO (1) WO2024204260A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015516239A (ja) 2012-05-09 2015-06-11 アメディカ コーポレイション 生体用インプラント及び関連器具の表面の化学的性質を変化させる方法
JP2020512072A (ja) 2017-03-27 2020-04-23 シントクス テクノロジーズ インコーポレイテッド 生体用抗菌インプラント、ならびに関連する材料、装置及び方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7026904B2 (ja) * 2018-08-01 2022-03-01 株式会社フェローテックマテリアルテクノロジーズ セラミックス抗菌材料、抗菌部品、抗菌部品の製造方法およびセラミックス複合材料
CN111840652B (zh) * 2020-06-11 2021-12-17 上海禾麦医学科技有限公司 骨修复材料及其制备方法
JP7640249B2 (ja) * 2020-11-17 2025-03-05 デンカ株式会社 窒化ケイ素粉末及びその製造方法、並びに、窒化ケイ素焼結体の製造方法
CN113248279A (zh) * 2021-05-22 2021-08-13 李善华 一种多孔的轻质陶瓷颗粒及其制备方法
CN115366512A (zh) * 2022-08-08 2022-11-22 浙江亚厦装饰股份有限公司 一种高硬度抗菌木塑的制备方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015516239A (ja) 2012-05-09 2015-06-11 アメディカ コーポレイション 生体用インプラント及び関連器具の表面の化学的性質を変化させる方法
JP2020512072A (ja) 2017-03-27 2020-04-23 シントクス テクノロジーズ インコーポレイテッド 生体用抗菌インプラント、ならびに関連する材料、装置及び方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2024204260A1

Also Published As

Publication number Publication date
CN120882313A9 (zh) 2025-11-25
JPWO2024204260A1 (https=) 2024-10-03
WO2024204260A1 (ja) 2024-10-03
CN120882313A (zh) 2025-10-31

Similar Documents

Publication Publication Date Title
EP1694602B1 (en) Aluminium oxide powder produced by flame hydrolysis and having a large surface area
Valappil et al. Controlled delivery of antimicrobial gallium ions from phosphate-based glasses
US6746767B2 (en) Superparamagnetic oxidic particles, processes for their production and their use
Pontremoli et al. Strontium-releasing mesoporous bioactive glasses with anti-adhesive zwitterionic surface as advanced biomaterials for bone tissue regeneration
Ergun Effect of Ti ion substitution on the structure of hydroxylapatite
CN101142139A (zh) 通过火焰喷雾热解制备的抗微生物和抗真菌粉末
EP2010687A2 (de) Hartmetallkörper, der aus einer mischung gebildet ist, die eine wolfram-cobalt-kohlenstoff-phase enthält
KR20160015323A (ko) 제타 양성 수소화 나노다이아몬드 분말, 제타 양성 싱글 디지트 수소화 나노다이아몬드 분산물 및 그 제조 방법
Kolmas et al. Effect of carbonate substitution on physicochemical and biological properties of silver containing hydroxyapatites
Megha et al. Structural and biological properties of novel Vanadium and Strontium co-doped HAp for tissue engineering applications
Roy et al. Biomimetic synthesis of nanocrystalline silver sol using cysteine: stability aspects and antibacterial activities
KR100904696B1 (ko) 작은 비표면 및 현저한 증점 효과를 갖는 입자
El‐Naggar et al. Microstructure, morphology and physicochemical properties of nanocomposites containing hydroxyapatite/vivianite/graphene oxide for biomedical applications
EP4342849A1 (en) Titanium oxide particles and method for producing same
EP4691243A1 (en) Antibacterial agent and method for using composition containing silicon nitride as antibacterial agent
JP5035720B2 (ja) 導電性黒色粉末の製造方法と導電性黒色膜
Karpov et al. Formation of Nd1–x Bi x FeO3 nanocrystals under conditions of glycine-nitrate synthesis
Fadeeva et al. Copper-substituted tricalcium phosphates
JP2013523586A (ja) ヤヌス型鉄−ケイ素酸化物粒子
JP2003064401A (ja) 抗菌・防かび性に優れたNi系粉末およびその製法、並びに該Ni系粉末を含む抗菌・防かび性に優れた材料、樹脂および部材
Jokic et al. The influence of silicon substitution on the properties of spherical-and whisker-like biphasic α-calcium-phosphate/hydroxyapatite particles
Shirazi et al. Mechanochemical synthesis and characterization of silver (Ag+) and tantalum (Ta5+) doped calcium silicate nanopowders
Hannora Preparation of calcium manganese phosphate by mechanochemical synthesis of manganese and hydroxyapatite
EP1717199A1 (en) Sintered body of titanium compound
EP4691504A1 (en) Biological material, powder composition, bone prosthetic material, and method for using composition containing composite compound as biological material

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251020

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR